# Nymox Pharmaceutical Corporation (NYMX)

Source: https://www.quantisnow.com/company/NYMX
Generated: 2026-11-22T23:46:35.926Z

- Ticker: NYMX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Website: nymox.com

## About

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, The Bahamas.

## Latest NYMX news and filings

- 2023-11-15 00:49 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-5085788)
- 2023-11-09 17:55 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-5074057)
- 2023-11-06 14:59 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-5061263)
- 2023-09-25 20:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4986460)
- 2023-08-29 19:34 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4943055)
- 2023-08-14 19:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4893183)
- 2023-08-02 17:40 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4833976)
- 2023-07-31 17:54 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4818924)
- 2023-07-25 20:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4793015)
- 2023-07-25 20:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4792990)
- 2023-07-13 14:16 UTC [Nymox Update](https://www.quantisnow.com/insight/nymox-update-4750706)
- 2023-07-12 21:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4748024)
- 2023-07-12 13:30 UTC [Leadership Update] [Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox](https://www.quantisnow.com/insight/nymox-announces-appointment-of-patrick-doody-as-vice-president-and-4745334)
- 2023-07-07 21:02 UTC [NYMOX Update](https://www.quantisnow.com/insight/nymox-update-4732386)
- 2023-07-06 17:37 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-4726595)
- 2023-07-06 14:53 UTC [Market Chatter] [Nymox Pharmaceutical shares are trading lower after the company received a Nasdaq delisting notice.](https://www.quantisnow.com/insight/nymox-pharmaceutical-shares-are-trading-lower-after-the-company-received-4725711)
- 2023-07-06 14:30 UTC [Market Insight] [Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-caribou-biosciences-shares-are-trading-higher-by-around-58-4725595)
- 2023-07-06 13:12 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-4725098)
- 2023-07-06 12:03 UTC [Market Insight] [Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-vbi-vaccines-are-trading-lower-by-over-23-here-4724483)
- 2023-07-05 22:11 UTC [Nymox Delisting from NASDAQ](https://www.quantisnow.com/insight/nymox-delisting-from-nasdaq-4722886)
- 2023-07-05 13:12 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-4718232)
- 2023-07-04 17:37 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-4716598)
- 2023-07-03 17:37 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-4714395)
- 2023-06-29 21:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4705545)
- 2023-06-29 20:24 UTC [SEC Form 6-K] [SEC Form 6-K/A filed by Nymox Pharmaceutical Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-6-ka-filed-by-nymox-pharmaceutical-corporation-amendment-4704896)
- 2023-06-27 21:21 UTC [Market Chatter] [Nymox Pharmaceutical Says Terminated Employment Of Each Of CFO Christopher Riley And COO Randall Lanham](https://www.quantisnow.com/insight/nymox-pharmaceutical-says-terminated-employment-of-each-of-cfo-christopher-4692669)
- 2023-06-27 21:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4692606)
- 2023-05-18 20:09 UTC [SEC Form 4] [SEC Form 4 filed by Robinson James George (Amendment)](https://www.quantisnow.com/insight/sec-form-4-filed-by-robinson-james-george-amendment-4527977)
- 2023-05-12 20:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-nymox-pharmaceutical-corporation-4497615)
- 2023-05-10 14:00 UTC [Market Insight] [Nymox Provides Current Update](https://www.quantisnow.com/insight/nymox-provides-current-update-4477479)
- 2023-05-10 14:00 UTC [Nymox Provides Current Update](https://www.quantisnow.com/insight/nymox-provides-current-update-4477412)
- 2023-05-02 12:29 UTC [SEC Form 20-F filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-nymox-pharmaceutical-corporation-4425360)
- 2023-04-03 13:30 UTC [Nymox Provides Corporate Update](https://www.quantisnow.com/insight/nymox-provides-corporate-update-4286497)
- 2023-03-31 20:16 UTC [SEC Form NT 20-F filed by Nymox Pharmaceutical Corporation](https://www.quantisnow.com/insight/sec-form-nt-20-f-filed-by-nymox-pharmaceutical-corporation-4281975)
- 2023-03-27 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-4250379)
- 2023-03-21 14:04 UTC [Market Insight] [Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer](https://www.quantisnow.com/insight/nymox-announces-appointment-of-christopher-r-riley-as-chief-financial-4228936)
- 2023-03-21 14:00 UTC [Leadership Update] [Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer](https://www.quantisnow.com/insight/nymox-announces-appointment-of-christopher-r-riley-as-chief-financial-4228805)
- 2023-03-15 13:33 UTC [Market Insight] [Nymox Officially Granted Extension Until July 3, 2023 To Regain Listing Requirements](https://www.quantisnow.com/insight/nymox-officially-granted-extension-until-july-3-2023-to-regain-4204504)
- 2023-03-15 13:30 UTC [Nymox Officially Granted Extension to Regain Listing Requirements](https://www.quantisnow.com/insight/nymox-officially-granted-extension-to-regain-listing-requirements-4204447)
- 2023-03-14 21:33 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-4201683)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NYMX
- Earnings history: https://www.quantisnow.com/earnings/NYMX
- Dividend history: https://www.quantisnow.com/dividends/NYMX
- Insider transactions: https://www.quantisnow.com/insiders/NYMX
- Options chain: https://www.quantisnow.com/options/NYMX
- SEC 8-K filings only: https://www.quantisnow.com/company/NYMX/8-k
- RSS and alerts for NYMX: https://www.quantisnow.com/docs/rss-feeds.md
